Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Several new and even more effective GLP-1RAs are expected to reach the market in the next few years that may bring additional anti-addiction or mental health benefits
Semaglutide is administered as a once-weekly subcutaneous injection (marketed as Ozempic for diabetes and Wegovy for weight management) or as a daily oral tablet (Rybelsus)
The GLP-1 consumer is a new archetype: affluent, health-motivated, newly body-confident, and actively looking to spend the money they're saving on food on products that support their transformation or correct its side effects
The Chartered Trading Standards Institute (CTSI) has even described unsafe cosmetic products as the biggest emerging threat to UK consumers, and they specifically call out nasal tanners as well as DIY lash lift kits and nail glue
01185-6/asset/4a8b6ac7-0944-49bb-a528-111e459b6c4e/main.assets/gr1.jpg)
